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Abstract We have examined the effect of trifluoroethanol 
(TFE) on the solution behaviour of three amphipathic peptides. 
One of the peptides, containing three heptad repeat units (Ac-
YS-(AKEAAKE)3GAR-NH2), remained monomeric under con-
ditions where TFE induced a two-state transition from a random 
coil to an a-helix. In contrast, the TFE-induced a-helical 
formation of two peptides derived from human apolipoproteins 
C-II and E was accompanied by the formation of discrete aimers 
and trimers, respectively. The apolipoprotein C-II peptide further 
aggregated to form ß-sheet at higher concentrations of TFE 
(50% v/v). The results suggest a class of peptides capable of 
discrete self-association in the presence of cosolvents which 
favour intramolecular hydrogen bonding. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The propensity of specific amino acid sequences to adopt 
secondary and higher order structures can be explored using 
model peptides and solution conditions which mimic typical 
environments found within proteins. Trifluoroethanol (TFE) 
has been widely used as a cosolvent to mimic the microsolva-
tion effects created by long-range interactions within protein 
tertiary structures [1,2]. The importance of such interactions is 
illustrated by recent studies showing environment-dependent 
folding of an amino acid sequence located at different posi-
tions within the same protein sequence [3]. TFE provides a 
more hydrophobic and less basic environment than that exist-
ing in aqueous solution. The decreased capacity of TFE to 
accept hydrogen bonds is considered to weaken the interac-
tions between peptide and solvent leading to stronger intra-
molecular interactions and increased formation of secondary 
structure [4,5]. TFE also affects tertiary and quaternary inter-
actions in proteins and peptides. For hen egg-white lysozyme 
[6], TFE generates a partially denatured form resembling a 
molten globule. Zhou et al. [7] observed the monomerisation 
of a dimeric a-helical coiled-coil in solvents containing 50% 
TFE. 
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We considered the possibility that promotion of helix for-
mation by TFE may facilitate self-association of amphipathic 
helices to form coiled-coil structures. We examined three am-
phipathic ос-helices. One contained three heptad repeats sim-
ilar to those found in a secreted polymorphic malarial antigen 
[8] while the other two were based on sequences found in 
human apolipoprotein (apo) C-II and apo E corresponding 
to A and G* class helices respectively [9]. TFE promoted oc-
helix formation in all three peptides and in the case of the apo 
C-II and apo E peptides generated discrete dimers and trimers 
respectively. 
2. Materials and methods 
2.1. Peptide synthesis and purification 
Peptide С (apo C-II19-39 Ac-KESLSSYWESAKTAAQDLYEK-
NH2; .Mr = 2475 [10]), corresponding to the indicated sequence in 
mature human apo C-II with the addition of an acetylated N-terminus 
and an amide group at the C-terminus and peptide E (apo Е2бз-28б 
SWFEPLVEDMQRQWAGLVEKVQAA, Afr = 2818 [11]) corre-
sponding to the indicated sequence in mature human apo E, were 
synthesised by solid-phase peptide synthesis using an Applied Biosys-
tems model 431A peptide synthesiser. Rink resin and F-moc amino 
acids were purchased from AusPep (Victoria, Australia), and Wang 
(HMP) resin was purchased from NovaBiochem. Crude peptide С was 
purified on a Brownlee semi-preparative reversed phase C-18 HPLC 
system employing a linear gradient of 0.5% min-1 of 20^10% aceto-
nitrile containing 0.1% TFA at 4 ml/min to elute the peptide. Frac-
tions were analysed by MALDI-TOF mass spectrometry and the de-
sired fractions pooled and lyophilised three times from water. Peptide 
E was purified by reversed-phase FPLC on a 3 ml Resource column 
(Pharmacia) equilibrated in 0.1% (v/v) TFA at a flow rate of 1 ml/min 
and eluted with a 50 ml gradient of 0-100% acetonitrile, 0.1% TFA. 
Desired fractions were identified by MALDI-TOF mass spectrometry, 
combined and re-purified on a 3 ml Resource column, with a 10 ml, 
0-100% gradient of acetonitrile containing 0.1%) TFA, lyophilised and 
stored at -20°C. Peptide H3 (Ac-YS(AKEAAKE)3GAR-NH2 ; 
Mt = 2777) with an acetylated N-terminus and an amide group at 
the C-terminus was kindly provided by Robin Anders (Walter and 
Eliza Hall Institute for Medical Research, Melbourne) and synthe-
sised using procedures similar to those described elsewhere [8]. Purity 
was assessed by mass spectrometry. 
2.2. Determination of the densities and viscosities of aqueous 
mixtures of TFE 
Density measurements of mixtures of 2,2,2-trifluoroethanol (pur-
chased from Sigma, St. Louis, MO) and water were performed at 
20°C using an Anton Paar DMA02C density meter. The variation 
in density (p) with increasing TFE content followed the relation 
p = 0.9982 + 5.0242X-0.1096X2 (1) 
where x denotes the volume fraction of TFE per total volume of 
added water and TFE. Viscosities of aqueous mixtures of TFE and 
water were measured at 20°C with a Schott capillary viscometer. All 
viscosities (η) were measured relative to water and methanol stand-
ards [12]. The viscosities of aqueous mixtures of TFE followed the 
relationship 
η = 0.9355 + 2.04X + 1.355x2-7.532x3 + 4.464x4 (2) 
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Fig. 1. Circular dichroism spectra of peptides С (16 μΜ, panel A), E (14 μΜ, panel В) and H3 (16 μΜ, panel С) in 0 (solid line), 20 (dashed 
line), 30 (dotted line) and 50 (dash-dotted line) % (v/v) trifluoroethanol and 0.1 M KF, 20 mM potassium phosphate buffer, pH 7.4. 
2.3. Circular dichroism 
Circular dichroism spectra were recorded at 20°C on an AVIV 
62DS model spectrometer, using a 1 mm pathlength quartz cuvette. 
The instrument was routinely calibrated with an aqueous solution of 
rf-10-camphorsulphuric acid. Ellipticities are reported as mean residue 
ellipticity (MRE) in deg cm2/dmol. Peptide concentrations were deter-
mined by absorption spectroscopy at 280 nm with extinction coeffi-
cients calculated according to Gill and von Hippel [13]. The a-helicity 
was calculated using the equation described by Chen et al. [14], which 
takes into consideration the chain-length dependence of helices. The 
calculated maximum MREs at 222 nm for peptides H3, C-II, and E 
were 35 596, 34666 and 35270 deg cm2/dmol, respectively. The pro-
portion of ß-structure in peptide С at high concentrations of TFE was 
determined by fitting the CD spectrum between 190 and 240 nm to the 
sum of contributions from four structural species: ос-helix, ß-sheet, 
random coil and ß-turn. The sample spectra used for the fitting pro-
cedure were derived from Yang et al. [15]. 
2.4. Analytical ultracentrifugation 
Sedimentation experiments were conducted using a Beckman XL-A 
analytical ultracentrifuge equipped with absorption optics, an An60-
Ti rotor and either conventional or synthetic boundary double-sector 
charcoal-filled epon centrepieces containing quartz windows. Sedimen-
tation coefficients (s) were calculated by direct fitting of sedimentation 
velocity boundary data by numerical integration of the Lamm equa-
tion (Schuck, MacPhee and Howlett, in preparation). These values 
were corrected for the density (p) and viscosity (η) of aqueous mix-
tures of TFE to obtain i2o,w values. Sedimentation equilibrium experi-
ments were conducted at 20°C and 40000 rpm for approximately 15 
h. At equilibrium, scans of the solution column were acquired at three 
different wavelengths. In the absence of TFE, the rotor speed was 
then increased to 50000 rpm to allow simultaneous fitting of data 
at 40 000 and 50 000 rpm to obtain the molecular weight of the pep-
tide and the contribution of non-sedimenting species to the baseline 
optical density. In all cases the baseline optical density contributed 
less than 5% of the total optical density. The data at three wave-
lengths and two speeds were analysed using the program SEDEQ1B 
(kindly provided by Allen Minton, Bethesda, MD). Values for the 
molecular weights (M) and partial specific volumes (v) of the peptides 
were calculated from the amino acid composition [16]. 
3. Results 
The circular dichroism spectra of peptides C, E and H3 
were measured in aqueous mixtures of TFE ranging from 0 
to 60% (v/v). Peptides E and H3 (Fig. 1B,C) both show a two-
state transition from random coil to a-helix, with a character-
istic isodichroic point at approximately 203 nm. In contrast, 
peptide С (Fig. 1A) shows a complex transition, suggesting a 
conversion from random coil to a-helix and to ß-sheet at high 
TFE concentrations. Fig. 2 shows the variation in a-helix 
content with TFE concentration. Peptides E (open triangles) 
and H3 (open circles) show a steady increase in a-helical 
content with TFE concentration, approaching a maximum 
of 80-90% at approximately 30% TFE (v/v). The behaviour 
of peptide С (filled circles) parallels that of the other two 
peptides at low TFE concentrations while the a-helix content 
decreases above 40%) TFE, concomitant with the formation of 
ß structure (approximately 40%> ß-sheet in 50% (v/v) TFE). 
Fig. 3 shows the sedimentation equilibrium distributions of 
peptide C, E and H3 in 0.1 M KF, 20 mM potassium phos-
phate buffer pH 7.4 and in the presence and absence of TFE 
(30%). The data are presented as plots of ln(absorbance) vs 
radius2 and normalised for the density of TFE. The linearity 
of the data indicates molecular weight homogeneity. Molec-
ular weight values for the peptides determined from non-lin-
ear regression of the data are summarised in Table 1. The 
molecular weight values for peptide H3 in the presence and 
absence of TFE are close to the values expected for the mono-
meric form of the peptide. The values obtained for peptides С 
and E suggest oligomerisation of the peptides in TFE to form 
discrete dimers and trimers respectively. Molecular weight val-
ues for peptides С and E in the presence of 30% TFE were 
determined over a range of starting concentrations from 0.04 
to 0.5 mg/ml. Analysis of the data showed no significant de-
pendence of molecular weight on concentration suggesting 
stable, high affinity complexes. The small difference between 
the measured molecular weights and the predicted molecular 
weights of the oligomers may indicate the presence of a small 
fraction of non-associating peptide or result from a direct 
effect of TFE on the partial specific volume of the peptides. 
This latter effect, which might arise from preferential interac-
% TFE (v/ V) 
Fig. 2. The variation in the a-helix content of peptides E (open tri-
angles), H3 (open circles) and С (filled circles) with TFE concentra-
tion. The ellipticity was derived from the TFE titrations in Fig. 1; 
the ellipticity at 222 nm was converted to percentage a-helix using 
the value calculated for the maximum ellipticity for a helical peptide 
of a given length (see Section 2). 
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Fig. 3. Sedimentation equilibrium profiles for peptides E (14 μΜ, 
panel A), H3 (16 μΜ, panel В) and С (16 μΜ, panel С) in 0.1 M 
KF, 20 mM potassium phosphate buffer, pH 7.4, and in the pres-
ence (open triangles) and absence (open circles) of 30% (v/v) TFE. 
The data are normalised for the effect of the density (p) of TFE 
and are presented as plots of ln(c) vs radius2 where the radial posi-
tion is in cm and с represents the absorbance at 240 nm. 
en 
см 
in 
с 
tt) 
Ω 
"CD 
О 
" Q . 
О 
radial position (cm) 
Fig. 4. Sedimentation velocity scans acquired at 15 min intervals at 
40000 rpm for 0.2 mM peptide E in 30% (v/v) TFE containing 0.1 
M KF, 20 mM potassium phosphate buffer, pH 7.4. Scans (a-g) 
were acquired at 15, 30, 45, 60, 75, 90 and approximately 1080 min 
after the start of centrifugation. The first scan has been offset from 
zero by 1.2 optical density units. Scans b-f have been offset by 1.0, 
0.8, 0.6, 0.4 and 0.2 optical density units respectively. The final 
scan, at 18 h, represents the peptide at equilibrium. The solid lines 
are simulations for the best-fit value of s = 0.97 S and a constrained 
value of the buoyant molecular mass, M(l—vp), of 1197. 
tions of peptide with solvent in solutions of TFE and water, 
would be expected to apply similarly to the three peptides 
studied. 
The oligomers were further characterised by sedimentation 
velocity experiments. An important advantage of the sedimen-
Table 1 
The hydrodynamic properties of amphipathic peptides in the pres-
ence and absence of TFE 
Peptide 
С 
С 
E 
E 
НЗ 
НЗ 
Concentration of 
TFE in 
0 
30 
0 
30 
0 
30 
% (v/v) 
MW 
predicted" 
2475 
(4950) 
2818 
(8450) 
2777 
2777 
MW 
expected*1 
2560 
4650 
2840 
7940 
2770 
2830 
•?20,w 
(S)c 
0.46 
1.19 
0.47 
0.97 
0.45 
0.52 
aThe predicted molecular weight of the peptide based on the amino 
acid sequence. The predicted molecular weights of self-associated spe-
cies assuming dimer and trimer for peptides С and E, respectively, are 
shown in parentheses. 
bThe molecular weight of the peptide from sedimentation equilibrium 
data. Values of v used in the analysis were calculated from amino acid 
composition [16]. These values were 0.723, 0.738 and 0.730 ml/g for 
peptides C, E and H3 respectively. 
cThe sedimentation coefficients in svedberg units (S = 10_13/s) are re-
ported as 2^0,w values, corrected for the viscosity and density of the 
solvent. 
tation velocity approach is the ability to constrain the fitting 
procedure to values of the buoyant molecular mass values, 
M(l—vp), obtained from sedimentation equilibrium analysis. 
This strategy avoids the need to assign independent values to 
v, yielding sedimentation coefficients directly. The results in 
Fig. 4 show sedimentation velocity profiles for peptide E in 
the presence of 30% TFE at various times after the start of 
centrifugation. The fitted lines through the data assume a 
single sedimenting species. Sedimentation velocity data for 
peptide E in the absence of TFE, and peptides С and H3 in 
the presence and absence of TFE also fit to a single species 
(Table 1). The increases in the sedimentation coefficients of 
the peptides in the presence of TFE can partly be attributed to 
the formation of more compact helical structures as indicated 
by the results in Fig. 1. The much larger increases observed 
for peptides С and E compared to peptide H3 are best ex-
plained by a TFE-induced self-association of these peptides. 
4. Discussion 
The addition of TFE to peptide H3 induces a-helix forma-
tion under conditions where the peptide remains monomeric. 
This behaviour may be compared with that of a similar am-
phipathic peptide E(AEKAAKE)aAEK where the heptad re-
peat differs from peptide H3 only in the order of the lysine 
and glutamate residues in the b and с positions [17]. While 
268 CE. MacPhee et al.lFEBS Letters 416 (1997) 265-268 
this peptide contained 65% α-helical structure in solution it 
was also monomeric in the presence and absence of TFE. 
Replacement of the alanine by leucine in this peptide caused 
self-association of the peptide in aqueous solution, an effect 
prevented by the addition of 25% TFE. The ability of TFE to 
prevent peptide association has also been observed for other 
amphipathic peptides. For the peptide series Ac-
(KLEALEG)n-K-NH2 where n=4 or 5, the presence of dimers 
in 0.1%> aqueous trifluoroacetic acid was prevented by the 
addition of TFE under conditions where the a-helical content 
was conserved [18]. These studies, which are similar to the 
results obtained with peptide H3 (Figs. 1-3), lead to the 
view that TFE stabilises ос-helices in the monomeric state. 
The ability of TFE to stabilise monomeric a-helical peptides 
was attributed to the partially hydrophobic nature of TFE 
which stabilises the hydrophobic face of the helix while the 
weaker basicity of TFE decreases hydrogen bonding of amide 
protons with the solvent leading to a strengthening of intra-
molecular hydrogen bonds. 
For peptides С and E, TFE induced ос-helix structure and 
the formation of dimers and trimers respectively. These results 
differ from the results described above where TFE disrupted 
tertiary and quaternary interactions. Multimene amphipathic 
peptide complexes in aqueous solution have been extensively 
studied and, in the case of GCN4 leucine zipper derivatives, 
rules have been developed to predict the state of oligomerisa-
tion [19,20]. The structural basis for the TFE-induced self-
association of peptides С and E to form discrete complexes 
is currently unclear. These peptides are typical of the amphi-
pathic repeating units within apolipoprotein sequences. Pep-
tide С is classified as a 'class A' helix characterised by negative 
amino acids in the centre of the polar face and positive amino 
acids at the polar-non-polar interface whereas peptide E is a 
'G* helix', which possesses a more random distribution of 
charges on the polar face, and is typical of helices found in 
globular proteins [9]. These amphipathic regions are consid-
ered key structural determinants of the interactions of apolip-
oproteins with lipid surfaces. Circular dichroism studies indi-
cate both peptides E [11] and С (results not shown) form a 
high degree of oc-helicity upon binding to model lipid vesicles. 
In addition, NMR studies show peptide E binds to SDS mi-
celles forming a helix-bend-helix structure [11]. One explana-
tion for the effect of TFE on peptides С and E is that these 
sequences have evolved to present a hydrophobic face to the 
lipid surface with ionic interactions mediating intrachain in-
teractions at the lipid surface. A similar model has been pro-
posed to describe the peptide-induced formation of phospho-
lipid discs, in which extensive self-association involving ionic 
interactions between peptides stabilises the edges of a lipid 
bilayer structure [21,22]. In the absence of lipid, TFE may 
promote these ionic interactions with the formation of discrete 
peptide oligomers. 
Peptide С is monomeric, random coil and stable in aqueous 
solution, and is dimeric and ot-helical in aqueous solutions 
containing 30%) (v/v) TFE. However, in high concentrations 
of TFE (50%o v/v), the peptide acquires a high proportion of 
ß-sheet structure (Fig. 1). CD spectroscopy and turbidometric 
studies show no indication of the formation of large, insoluble 
aggregates ; however, analytical ultracentrifugation of the pep-
tide in the ß-sheet conformation indicates the formation of 
sufficiently high molecular weight complexes as to rapidly 
sediment out of solution. This is similar to a result observed 
by Zhang et al. [23], studying peptides derived from the prion 
protein PrP. PrPgo-us is random coil in low salt media, but at 
physiological concentrations of salt, or in the presence of ace-
tonitrile, the peptide forms oligomeric ß-sheet structures. In 
both cases the acquisition of secondary structure appears to 
drive the formation of aggregates. These results for peptide С 
suggest a relationship between the acquisition of a or ß struc-
ture and the nature of the oligomers or aggregates formed. 
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